Methaqualone “Wolf of Wallstreet” powder – More information
Methaqualone (brand name Quaalude in the US and Mandrax in the UK) is a central nervous system (CNS) depressant of the quinazolinone class that acts as a sedative and hypnotic. The sedative–hypnotic activity of methaqualone was first noted by researchers in the 1950s and in 1962 methaqualone itself was patented in the US by Wallace and Tiernan. Its use peaked in the early 1970s as a hypnotic, for the treatment of insomnia, and as a sedative and muscle relaxant. It is still produced and used clandestinely as a recreational drug throughout the world. The drug was popular in the 1970s with hippies and in the disco club scene.
clinical data
Common names | Methaqualone, Quaaludes, “Ludes”, Mandrax, Sopor |
Substitutive name | Methaqualone |
Systematic name | 2-Methyl-3-(2-methylphenyl)-4(3H)-quinazolinone |
Psychoactive class | Depressant |
Chemical class | Quinazolinone |
Methaqualone dosage table
Threshold | 75 – 150 mg |
Light | 150 – 300 mg |
Common | 300 – 500 mg |
Strong | 500 – 600 mg |
Heavy | 600 mg + |
Methaqualone effect progress
Total | 5 – 8 hours |
Offset | 2 – 4 hours |
After effects | 6 – 8 hours |
Chemistry
Methaqualone, or 2-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone, is a compound of the quinazolinone class. Quinazolinone is a bicyclic structure containing a phenyl ring bound to another six-membered ring with two nitrogen members and a ketone group bound to R4. In methaqualone, this structure is substituted at R2 with a methyl group. Additionally, methaqualone contains a phenyl ring with a methyl group bound to R2 which is attached to the quinazolinone structure at R3.
Toxicity
Independent research should always be done to ensure that a combination of two or more substances is safe before consumption.
Overdose of methaqualone can lead to seizures, coma or death. Taking doses of over 300mg can be dangerous for first time users. Depending on the state of the user’s individual tolerance, doses of about 8,000mg per day can be fatal whilst others on even higher doses (of up to 20,000mg) may survive.
Although the exact lethal dosage of methaqualone has not been formally established, like many depressants, it is safe at appropriate dosages. Complications may arise when administered in excess or in combination with other depressants.
It is strongly recommended that one use harm reduction practices when using this substance.
Tolerance
Methaqualone is extremely addictive. Tolerance to the sedative-hypnotic effects develops within a couple of days of repeated administration. After that, it takes about 3 – 7 days for the tolerance to be reduced to half and 1 – 2 weeks to be back at baseline (in the absence of further consumption). Methaqualone presents cross-tolerance with all gabaergic depressants, meaning that after the consumption of methaqualone all compounds of the same class will have a reduced effect.
Abrupt discontinuation of methaqualone following regular dosing over several days can result in a withdrawal phase which includes rebound symptoms such as increased anxiety and insomnia. It is possible to gradually reduce the dose over the course of several days, which will lengthen the duration of the withdrawal period but reduce the perceived intensity.
Reviews
There are no reviews yet.